Use of continuous glucose monitoring in children and adolescents *
2012; Wiley; Volume: 13; Issue: 3 Linguagem: Inglês
10.1111/j.1399-5448.2011.00849.x
ISSN1399-5448
AutoresMoshe Phillip, Thomas Danne, Shlomit Shalitin, Bruce A. Buckingham, Lori M. Laffel, William V. Tamborlane, Tadej Battelino,
Tópico(s)Diabetes and associated disorders
ResumoPediatric DiabetesVolume 13, Issue 3 p. 215-228 Use of continuous glucose monitoring in children and adolescents † Moshe Phillip, Corresponding Author Moshe Phillip The Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel Molecular Endocrinology and Diabetes Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelMoshe Phillip, MDThe Jesse Z and Sara Lea Shafer Institute of Endocrinology and DiabetesNational Center for Childhood DiabetesSchneider Children's Medical Center of Israel14 Kaplan StreetPetah Tikva 49202Israel.Tel: +(972) 3-925-3731;fax: +(972) 3-925-3836;e-mail: [email protected]Search for more papers by this authorThomas Danne, Thomas Danne Diabetes Zentrum fur Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, GermanySearch for more papers by this authorShlomit Shalitin, Shlomit Shalitin The Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel Molecular Endocrinology and Diabetes Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorBruce Buckingham, Bruce Buckingham Pediatric Endocrinology, Stanford University, Stanford, CA, USASearch for more papers by this authorLori Laffel, Lori Laffel Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USASearch for more papers by this authorWilliam Tamborlane, William Tamborlane Pediatric Endocrinology, Yale University School of Medicine, New Haven, CT, USASearch for more papers by this authorTadej Battelino, Tadej Battelino Department of Pediatric Endocrinology, Diabetes Metabolism, University Children's Hospital, Ljubljana, SloveniaSearch for more papers by this authorfor the Consensus Forum Participants, for the Consensus Forum Participants A complete list of participants in the forum can be found in the acknowledgments.Search for more papers by this author Moshe Phillip, Corresponding Author Moshe Phillip The Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel Molecular Endocrinology and Diabetes Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelMoshe Phillip, MDThe Jesse Z and Sara Lea Shafer Institute of Endocrinology and DiabetesNational Center for Childhood DiabetesSchneider Children's Medical Center of Israel14 Kaplan StreetPetah Tikva 49202Israel.Tel: +(972) 3-925-3731;fax: +(972) 3-925-3836;e-mail: [email protected]Search for more papers by this authorThomas Danne, Thomas Danne Diabetes Zentrum fur Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, GermanySearch for more papers by this authorShlomit Shalitin, Shlomit Shalitin The Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel Molecular Endocrinology and Diabetes Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorBruce Buckingham, Bruce Buckingham Pediatric Endocrinology, Stanford University, Stanford, CA, USASearch for more papers by this authorLori Laffel, Lori Laffel Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USASearch for more papers by this authorWilliam Tamborlane, William Tamborlane Pediatric Endocrinology, Yale University School of Medicine, New Haven, CT, USASearch for more papers by this authorTadej Battelino, Tadej Battelino Department of Pediatric Endocrinology, Diabetes Metabolism, University Children's Hospital, Ljubljana, SloveniaSearch for more papers by this authorfor the Consensus Forum Participants, for the Consensus Forum Participants A complete list of participants in the forum can be found in the acknowledgments.Search for more papers by this author First published: 29 January 2012 https://doi.org/10.1111/j.1399-5448.2011.00849.xCitations: 89 † Consensus statement from the European Society for Pediatric Endocrinology, the Pediatric Endocrine Society and the International Society for Pediatric and Adolescent Diabetes. ‡ Conflict of interest: See Appendix for complete list of members and declaration of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001: 24: 1858– 1862. (C) . 2 Kaufman FR, Austin J, Neinstein A et al. Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes. J Pediatr 2002: 141: 625– 630. (C) . 3 Gandrud LM, Xing D, Kollman C et al. The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Ther 2007: 9: 307– 316. (C) . 4 Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011: 343: d3805 (A) . 5 Kordonouri O, Pankowska E, Rami B et al. Sensor-augmented pump therapy from diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 2010: 53: 2487– 2495. (A) . 6 Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomized controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2006: 114: 63– 67. (B) . 7 Bode BW. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther 2000: 2 (Suppl. 1): s35– s41. (B) . 8 Tiemey MJ, Potts RO, Eastman RC, Pitzer K, Ackerman NR, Fermi SJ. The GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor. Ann Med 2000: 32: 632– 641. (B) . 9 Kovatchev B, Anderson S, Heinemann L, Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 2008: 31: 1160– 1164. (A) . 10 Tansey MJ, Beck RW, Buckingham BA et al. Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the modified continuous glucose monitoring system (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther 2005: 7: 109– 114. (A) . 11 Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care 2007: 30: 1125– 1130. (A) . 12 DexCom. 2010 (available from: http://www.dexcom.com/sites/all/themes/dexcom/node-files/SEVEN_Plus_Users_Guide.pdf). (A) . 13 Sensor Accuracy Study for Minimed Paradigm Veo System. 2008 (available from: http://www.minimed.com.au/stage2010/downloads/6d-Sensor-Accuracy-Study-Veo.pdf). (A) . 14 Weinzimer SA, Beck RW, Chase HP et al. Diabetes Research in Children Network Study Group. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther 2005: 7: 675– 680. (A) . 15 Deiss D, Bolinder J, Riveline JP et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006: 29: 2730– 2732. (A) . 16 Hirsch IB, Abelseth J, Bode BW et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diab Technol Ther 2008: 10: 377– 383. (A) . 17 O'Connell MA, Donath S, O'Neal DN et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomized controlled trial. Diabetologia 2009: 52: 1250– 1257. (A) . 18 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008: 359: 1464– 1476. (A) . 19 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009: 32: 1378– 1383. (A) . 20 Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011: 34: 1– 6. (A) . 21 Bergenstal RM, Tamborlane WV, Ahmann A et al. for the STAR 3 Study Group. Effectiveness of sensor-augmented insulin pump therapy in type 1 diabetes. N Engl J Med 2010: 363: 311– 320. (A) . 22 Slover RH, Welsh JB, Criego A et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatric Diabetes 2011; July 3, DOI: 10.1111/j.1399-5448.2011.00793.x. In press. (A). 23 Buckingham B, Beck RW, Tamborlane WV et al. Diabetes Research in Children Network (DirecNet) Study Group. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007: 151: 388– 393, 393.e1–e2 (B). 24 Weinzimer S, Xing D, Tansey M et al. Diabetes Research in Children Network (DirecNet) Study Group. FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care 2008: 31: 525– 527. (B) . 25 Weinzimer S, Xing D, Tansey M et al. Diabetes Research in Children Network Study Group. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes 2009: 10: 91– 96. (C) . 26 Scaramuzza AE, Iafusco D, Rabbone I et al. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study. Diabetes Technol Ther 2011: 13: 99– 103. (B) . 27 Raccah D, Sulmont V, Reznik Y et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care 2009: 32: 2245– 2250. (A) . 28 DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177– 188. (A) . 29 Chase HP, Beck R, Tamborlane W et al. Randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005: 28: 1101– 1106. (A) . 30 JDRF CGM Study Group. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow up of the JDRF continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010: 12: 507– 515. (A) . 31 Chase HP, Roberts MD, Wightman C et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003: 111: 790– 794. (B) . 32 Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001: 24: 2030– 2034. (C) . 33 Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003: 111: 933– 938. (B) . 34 Golicki DT, Golicka D, Groele L, Pankowska E. Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2008: 51: 233– 240. (B) . 35 Yates K, Hasnat Milton A, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care 2006: 29: 1512– 1517. (A) . 36 Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006: 7: 159– 164. (B) . 37 Chase HP, Kim LM, Owen SL et al. Continuous glucose monitoring in children with type 1 diabetes. Pediatrics 2001: 107: 222– 226. (C) . 38 Blevins TC, Bode BW, Garg SK et al. AACE Continuous Glucose Monitoring Task Force, Rothermel C. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010: 16: 730– 745. (E) . 39 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K et al. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009: 32: 1947– 1953. (A) . 40 Svoren B, Svoren BM, Volkening LK et al. Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr 2007: 150: 279– 285. (C) . 41 Rewers A, Rewers A, Chase HP et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 287: 2511– 2518. (C) . 42 Buckingham B, Block J, Burdick J et al. Diabetes Research in Children Network: Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther 2005: 7: 440– 447. (C) . 43 Weinzimer S, Miller K, Beck R et al. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care 2010: 33: 17– 22. (A) . 44 Jeha GS, Karaviti LP, Anderson B et al. Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care 2004: 27: 2881– 2886. (C) . 45 Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care 2011: 34: 50– 52. (C) . 46 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010: 33: 1004– 1008. (B) . 47 Buckingham B, Chase HP, Dassau E et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010: 33: 1013– 1017. (B) . 48 Alemzadeh R, Loppnow C, Parton E, Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 2003: 5: 167– 173. (C) . 49 Wiltshire EJ, Newton K, McTavish L. Unrecognized hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors. J Paediatr Child Health 2006: 42: 758– 763. (C) . 50 Weintrob N, Schechter A, Benzaquen H et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med 2004: 158: 677– 684. (C) . 51 Schaepelynck-Bélicar P, Vague P, Simonin G, Lassmann-Vague V. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes Metab 2003: 29: 608– 612. (C) . 52 Bode BW, Steed RD, Schleusener DS, Strange P. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system. Endocr Pract 2005: 11: 157– 164. (C) . 53 Deiss D, Hartmann R, Hoeffe J, Kordonouri O. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diabetes 2004: 5: 117– 121. (C) . 54 Hay WW, Jr, Rozance PJ. Continuous glucose monitoring for diagnosis and treatment of neonatal hypoglycemia. J Pediatr 2010: 157: 180– 182. (C) . 55 Jefferies C, Solomon M, Perlman K, Sweezey N, Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005: 147: 396– 398. (C) . 56 O'Riordan S, Hoey H, George S, Costigan C. Can continuous glucose monitoring (CGMS) enhance the detection of CFRD in 167 cystic fibrosis children. Diabetes Care 2006: 72: A17. (C) . 57 O'Riordan S, Roche E, George S, Hoey H, Costigan C. Continuous glucose monitoring enhances the detection of cystic fibrosis related diabetes in children with cystic fibrosis. Diabetologia 2007: 50(suppl 1): OP 32, 0190): S1– S538. (C) . 58 O'Riordan SM, Hindmarsh P, Hill NR et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care 2009: 32: 1020– 1022. (C) . 59 Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M. Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 2001: 24: 863– 869. (C) . 60 Diabetes Research in Children Network (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the Glucowatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005: 28: 1929– 1935. (A) . 61 JDRF CGM Study Group. Satisfaction with continuous glucose monitoring in adults and youth with type 1 diabetes. Diabet Med 2011. In press. (A). 62 Diabetes Research In Children Network (DirecNet) Study Group, Buckingham B, Xing D, Weinzimer S et al. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes 2008: 9: 142– 147. (C) . 63 Messer L, Ruedy K, Dongyuan X et al. Diabetes Research in Children Network (DirectNet) Study Group. Educating families on real time continuous glucose monitoring: the DirectNet Navigator pilot study experience. Diabetes Educ 2009: 35: 124– 135. (C) . 64 Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999: 37: 126– 139. (C) . 65 Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic score scales in healthy and patient populations. Med Care 2001: 39: 800– 812. (C) . 66 Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care 2003: 26: 631– 637. (C) . 67 Laffel LM, Connell A, Vangsness L, Goebel-Fabbri A, Mansfield A, Anderson BJ. General quality of life in youth with type 1 diabetes: relationship to patient management and diabetes-specific family conflict. Diabetes Care 2003: 26: 3067– 3073. (C) . 68 Wake M, Hesketh K, Cameron F. The Child Health Questionnaire in children with diabetes: cross-sectional survey of parent and adolescent-reported functional health status. Diabet Med 2000: 17: 700– 707. (C) . 69 Hesketh KD, Wake MA, Cameron FJ. Health-related quality of life and metabolic control in children with type 1 diabetes: a prospective cohort study. Diabetes Care 2004: 27: 415– 420. (C) . 70 Hoey H, Aanstoot HJ, Chiarelli F et al. Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care 2001: 24: 1923– 1928. (C) . 71 Grey M, Boland EA, Yu C, Sullivan-Bolyai S, Tamborlane WV. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 1998: 21: 909– 914. (C) . 72 Guttmann-Bauman I, Flaherty BP, Strugger M, McEvoy RC. Metabolic control and quality-of-life self-assessment in adolescents with IDDM. Diabetes Care 1998: 21: 915– 918. (C) . 73 Kashmer L, Clarke W, Gurka M, Elchuri S, Nyer M, Gonder-Frederick L. Predictors of parental interest in continuous glucose monitoring for children with type 1 diabetes. Diabetes Technol Ther 2009: 11: 373– 378. (C) . 74 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Lawrence JM, Laffel L et al. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 2010: 33: 2175– 2177. [Epub 2010 Aug 9]. Erratum in: Diabetes Care 2010: 33: 725. (A). 75 Wysocki T, Cheng J, Beck RW et al. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther 2010: 12: 679– 684. (B) . 76 Ritholz M. Is continuous glucose monitoring for everyone? Consideration of psychosocial factors. Diabetes Spectr 2008: 21: 287– 289. (C) . 77 Tansey M, Laffel L, Cheng J et al. Satisfaction with continuous glucose monitoring in adults and youth with Type 1 diabetes. Diabet Med 2011: 28: 1118– 1122. (B) . 78 Huang ES, O'Grady M, Basu A et al. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010: 33: 1269– 1274. (B) . 79 Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther 2009: 11: 93– 97. (C) . 80 Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA. Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system. Diabetes Technol Ther 2009: 11: 207– 210. (C) . 81 Choudhary P, Stephanie Amiel A. Clinical use of automated insulin suspension during hypoglycemia: results of a user evaluation study. Basel: ATTD, 2010. (C) . Citing Literature Volume13, Issue3May 2012Pages 215-228 ReferencesRelatedInformation
Referência(s)